We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
SERPINF1
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • SERPINF1
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

SERPINF1 is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 289.38
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 638.2
Number of samples 362
Samples
Sample Description pTPM
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 2737.2
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 2199.9
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 2005.9
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 1996.3
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 1970.3
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 1877.6
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 1809.6
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 1770.8
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 1691.5
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 1653.7
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 1619.5
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 1608.6
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 1595.6
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 1532.6
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 1523.1
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 1502.8
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 1469.8
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 1426.4
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 1418.1
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 1399.2
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 1383.1
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 1370.4
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 1370.0
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 1367.0
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 1357.1
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 1315.1
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 1311.5
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 1307.0
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 1280.8
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 1257.7
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 1256.0
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 1253.7
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 1223.3
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 1216.5
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 1205.5
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 1177.5
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 1155.8
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 1148.7
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 1141.5
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 1121.2
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 1117.4
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 1116.4
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 1112.9
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 1108.1
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 1099.0
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 1089.2
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 1082.6
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 1082.3
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 1069.8
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 1066.6
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 1052.0
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 1048.4
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 1044.7
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 1034.6
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 1018.0
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 1015.5
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 1014.2
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 1012.1
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 1001.7
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 1001.5
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 997.0
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 989.8
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 988.4
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 980.2
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 971.7
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 969.8
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 968.4
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 966.2
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 942.3
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 921.3
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 919.7
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 915.6
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 904.2
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 902.6
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 900.6
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 883.9
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 882.0
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 878.7
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 877.6
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 870.6
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 869.4
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 865.6
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 860.2
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 859.1
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 854.6
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 853.0
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 852.3
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 851.9
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 851.8
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 848.4
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 840.6
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 829.2
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 828.5
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 826.1
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 824.4
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 823.0
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 822.7
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 822.5
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 821.0
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 820.6
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 818.2
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 816.8
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 816.5
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 808.3
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 807.8
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 802.2
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 799.2
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 798.2
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 791.6
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 789.7
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 785.2
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 783.5
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 782.4
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 779.5
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 777.4
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 775.6
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 774.1
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 771.4
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 768.5
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 763.6
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 760.3
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 757.0
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 756.6
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 746.6
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 746.2
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 744.4
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 741.2
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 739.7
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 739.2
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 737.9
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 727.9
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 724.3
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 721.5
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 719.7
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 707.7
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 703.1
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 700.5
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 700.5
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 699.9
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 698.9
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 691.4
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 682.7
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 679.0
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 672.7
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 668.2
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 667.7
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 662.7
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 661.7
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 660.7
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 660.2
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 654.6
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 648.9
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 647.1
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 644.7
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 641.4
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 639.4
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 637.9
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 636.2
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 635.6
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 630.5
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 627.8
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 626.7
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 622.2
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 619.4
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 619.4
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 615.9
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 614.9
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 611.7
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 611.5
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 607.4
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 605.8
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 603.9
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 603.0
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 598.0
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 590.3
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 579.5
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 578.5
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 578.4
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 577.3
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 576.0
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 574.4
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 572.7
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 571.9
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 571.7
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 569.9
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 568.6
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 565.9
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 564.4
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 561.3
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 559.8
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 558.4
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 555.6
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 549.8
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 549.8
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 545.6
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 543.7
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 539.2
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 534.1
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 533.1
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 532.8
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 531.4
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 530.0
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 526.9
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 522.4
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 521.1
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 520.6
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 519.4
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 519.0
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 517.5
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 516.3
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 509.9
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 503.8
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 500.9
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 500.5
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 499.5
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 496.6
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 495.9
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 493.0
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 486.0
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 484.9
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 480.4
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 477.2
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 471.9
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 466.7
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 465.4
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 462.6
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 461.6
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 460.2
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 458.6
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 455.3
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 454.7
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 452.2
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 447.7
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 447.0
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 446.2
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 441.0
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 441.0
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 440.9
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 440.4
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 437.6
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 436.8
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 436.0
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 435.9
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 430.8
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 422.6
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 418.3
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 418.2
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 410.9
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 408.4
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 405.8
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 404.7
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 402.2
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 399.4
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 398.0
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 397.6
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 392.3
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 384.1
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 381.8
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 380.3
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 374.7
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 374.1
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 373.5
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 367.0
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 360.0
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 348.5
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 347.6
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 345.0
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 335.0
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 334.1
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 324.3
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 320.9
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 318.6
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 316.6
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 314.2
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 309.5
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 305.7
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 304.8
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 303.7
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 302.1
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 302.0
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 299.6
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 298.7
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 293.8
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 293.0
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 290.9
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 290.5
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 288.3
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 282.9
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 279.1
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 277.0
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 275.3
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 269.8
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 267.2
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 266.6
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 261.7
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 260.9
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 255.5
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 251.1
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 243.4
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 240.3
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 238.9
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 229.5
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 228.9
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 220.6
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 219.7
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 216.5
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 215.8
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 210.1
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 209.0
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 207.2
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 205.8
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 204.6
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 203.7
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 197.8
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 196.2
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 194.7
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 190.5
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 185.7
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 185.5
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 184.0
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 183.7
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 181.9
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 175.2
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 165.1
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 163.1
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 161.2
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 159.9
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 154.6
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 147.0
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 144.2
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 141.1
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 138.5
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 136.5
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 125.3
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 119.5
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 116.9
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 115.9
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 115.0
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 106.0
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 105.8
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 103.4
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 100.8
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 94.8
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 84.3
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 80.2
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 80.1
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 74.7
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 64.9
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 64.8
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 62.5
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 57.2
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 52.9
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 44.0
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 35.9
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 31.1
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 27.0
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 25.7
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 21.7
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 21.0
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 17.9
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 8.8
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 0.8
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

SERPINF1 is potential prognostic, high expression is favorable in Liver Hepatocellular Carcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 624.72
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 773.4
Number of samples 231
Samples
Sample Description pTPM
DO45155 69 years, male, NA, stage:2, alive, 2160 days 2361.2
DO45121 61 years, male, NA, stage:3, alive, 1530 days 2225.5
DO45197 51 years, male, NA, stage:2, alive, 1170 days 2198.0
DO50832 73 years, male, NA, stage:3, alive, 90 days 2167.4
DO50825 70 years, male, NA, stage:2, alive, 390 days 2154.2
DO45096 69 years, male, NA, stage:2, dead, 1290 days 2034.8
DO23529 72 years, male, NA, stage:4, alive, 930 days 2020.7
DO45259 65 years, male, NA, stage:3, alive, 330 days 1925.2
DO48717 54 years, male, NA, stage:4, dead, 180 days 1906.0
DO50783 62 years, male, NA, stage:3, alive, 480 days 1834.5
DO45227 57 years, female, NA, stage:2, alive, 1020 days 1816.9
DO50857 72 years, male, NA, stage:2, alive, 210 days 1806.5
DO50813 56 years, male, NA, stage:2, alive, 420 days 1747.3
DO48721 58 years, female, NA, stage:1, alive, 900 days 1743.7
DO45129 61 years, male, NA, stage:3, alive, 1470 days 1739.7
DO50811 62 years, male, NA, stage:1, alive, 450 days 1652.6
DO45159 65 years, male, NA, stage:3, alive, 1470 days 1618.7
DO23536 56 years, male, NA, stage:2, alive, 930 days 1611.0
DO45183 72 years, female, NA, stage:2, dead, 570 days 1601.9
DO45179 78 years, female, NA, stage:2, alive, 600 days 1570.8
DO48695 77 years, male, NA, stage:2, alive, 720 days 1539.7
DO45099 46 years, male, NA, stage:3, alive, 1590 days 1529.6
DO45247 31 years, female, NA, stage:2, alive, 210 days 1521.5
DO23552 80 years, female, NA, stage:1, alive, 810 days 1517.1
DO45257 46 years, male, NA, stage:3, alive, 810 days 1508.8
DO48736 76 years, female, NA, stage:1, alive, 600 days 1505.6
DO45177 81 years, female, NA, stage:3, alive, 1260 days 1488.5
DO45149 70 years, female, NA, stage:2, alive, 1260 days 1479.7
DO23528 45 years, female, NA, stage:2, alive, 1020 days 1398.4
DO48701 78 years, male, NA, stage:2, alive, 780 days 1380.5
DO48677 58 years, male, NA, stage:3, alive, 1140 days 1380.1
DO45137 38 years, male, NA, stage:1, alive, 1320 days 1366.4
DO50787 63 years, male, NA, stage:3, alive, 480 days 1355.5
DO45131 53 years, male, NA, stage:4, dead, 360 days 1329.4
DO45199 86 years, female, NA, stage:2, alive, 1350 days 1306.1
DO23548 78 years, female, NA, stage:1, alive, 840 days 1294.9
DO45233 83 years, male, NA, stage:3, alive, 900 days 1272.4
DO23512 60 years, male, NA, stage:1, alive, 1260 days 1263.1
DO45139 63 years, male, NA, stage:3, alive, 1320 days 1239.7
DO48733 72 years, male, NA, stage:2, alive, 600 days 1235.0
DO45109 63 years, male, NA, stage:2, alive, 1590 days 1226.4
DO50776 75 years, male, NA, stage:1, alive, 690 days 1223.4
DO45111 74 years, male, NA, stage:2, alive, 1590 days 1209.5
DO45261 74 years, male, NA, stage:3, alive, 990 days 1202.1
DO50802 49 years, male, NA, stage:2, alive, 930 days 1196.9
DO23514 64 years, male, NA, stage:2, alive, 1290 days 1194.1
DO45105 61 years, male, NA, stage:1, alive, 1680 days 1182.3
DO48737 52 years, male, NA, stage:1, alive, 720 days 1179.6
DO48761 55 years, male, NA, stage:2, alive, 870 days 1153.1
DO48746 76 years, male, NA, stage:3, alive, 570 days 1151.4
DO23538 67 years, male, NA, stage:2, alive, 450 days 1146.5
DO48759 73 years, male, NA, stage:3, alive, 720 days 1140.3
DO50820 77 years, female, NA, stage:3, alive, 510 days 1137.0
DO50819 72 years, female, NA, stage:2, alive, 510 days 1133.6
DO50855 47 years, male, NA, stage:2, alive, 570 days 1128.4
DO23516 69 years, male, NA, stage:3, dead, 20 days 1126.5
DO48760 70 years, female, NA, stage:2, alive, 690 days 1125.1
DO45215 65 years, male, NA, stage:2, alive, 1170 days 1112.2
DO45167 67 years, male, NA, stage:2, dead, 1440 days 1093.7
DO23550 69 years, male, NA, stage:1, alive, 990 days 1093.3
DO45173 63 years, male, NA, stage:3, alive, 1170 days 1090.1
DO45095 66 years, male, NA, stage:2, alive, 1620 days 1088.9
DO45281 83 years, male, NA, stage:4, alive, 750 days 1081.6
DO45255 81 years, male, NA, stage:3, alive, 720 days 1036.9
DO23513 76 years, male, NA, stage:3, alive, 1200 days 1034.7
DO45103 47 years, male, NA, stage:3, alive, 450 days 1003.5
DO23527 72 years, male, NA, stage:1, alive, 1050 days 1001.6
DO45207 68 years, male, NA, stage:1, alive, 1050 days 994.9
DO48742 76 years, male, NA, stage:2, alive, 600 days 988.2
DO50818 65 years, male, NA, stage:2, alive, 510 days 982.0
DO48712 50 years, male, NA, stage:2, alive, 810 days 972.0
DO50800 74 years, male, NA, stage:2, alive, 510 days 963.8
DO45097 69 years, male, NA, stage:3, alive, 1620 days 956.4
DO23544 67 years, male, NA, stage:2, alive, 960 days 953.2
DO23510 80 years, female, NA, stage:2, alive, 870 days 940.2
DO45101 63 years, male, NA, stage:2, alive, 1680 days 929.2
DO45171 56 years, male, NA, stage:3, alive, 600 days 911.9
DO45213 58 years, male, NA, stage:1, alive, 1200 days 905.1
DO50807 67 years, male, NA, stage:1, alive, 540 days 902.0
DO23535 67 years, male, NA, stage:1, alive, 960 days 897.0
DO48679 72 years, male, NA, stage:2, alive, 1200 days 887.0
DO45195 62 years, male, NA, stage:1, alive, 390 days 879.8
DO23524 71 years, female, NA, stage:2, alive, 1050 days 859.3
DO23539 77 years, male, NA, stage:1, alive, 1110 days 856.9
DO45219 78 years, male, NA, stage:2, alive, 1080 days 851.1
DO45141 73 years, male, NA, stage:2, alive, 1320 days 848.5
DO45091 56 years, male, NA, stage:2, dead, 1320 days 844.4
DO23533 61 years, male, NA, stage:2, alive, 900 days 841.9
DO23541 65 years, male, NA, stage:2, alive, 930 days 830.6
DO23508 79 years, female, NA, stage:2, alive, 390 days 827.3
DO45191 61 years, female, NA, stage:2, alive, 1200 days 820.1
DO45119 74 years, male, NA, stage:3, dead, 510 days 814.3
DO50859 77 years, male, NA, stage:2, alive, 180 days 812.2
DO48757 68 years, female, NA, stage:3, alive, 480 days 803.3
DO50816 63 years, male, NA, stage:2, alive, 390 days 803.2
DO45189 85 years, female, NA, stage:2, alive, 1200 days 802.6
DO45231 84 years, male, NA, stage:2, alive, 930 days 796.7
DO45094 76 years, male, NA, stage:3, alive, 1650 days 788.5
DO50839 47 years, female, NA, stage:3, alive, 330 days 774.8
DO45092 62 years, male, NA, stage:4, dead, 1200 days 762.0
DO45269 59 years, male, NA, stage:3, alive, 750 days 756.9
DO45187 32 years, female, NA, stage:1, alive, 1260 days 744.9
DO23517 62 years, male, NA, stage:2, alive, 1200 days 733.4
DO48700 78 years, female, NA, stage:2, alive, 810 days 719.3
DO23521 63 years, male, NA, stage:3, alive, 1110 days 709.4
DO45113 58 years, male, NA, stage:3, alive, 1560 days 706.7
DO48697 64 years, female, NA, stage:2, dead, 810 days 702.1
DO23537 79 years, male, NA, stage:2, dead, 900 days 694.9
DO45143 69 years, male, NA, stage:3, alive, 1290 days 686.8
DO50805 72 years, male, NA, stage:2, alive, 690 days 685.3
DO48674 80 years, male, NA, stage:2, alive, 1260 days 684.5
DO45205 67 years, female, NA, stage:2, dead, 90 days 682.5
DO48681 57 years, male, NA, stage:2, alive, 900 days 681.1
DO45203 71 years, female, NA, stage:2, alive, 1170 days 672.7
DO45229 74 years, male, NA, stage:1, alive, 990 days 671.1
DO48741 64 years, male, NA, stage:3, alive, 240 days 670.4
DO50789 73 years, female, NA, stage:2, alive, 570 days 664.1
DO45243 74 years, female, NA, stage:3, alive, 930 days 660.4
DO227801 77 years, female, NA, stage:1, alive, 660 days 657.1
DO45223 67 years, male, NA, stage:4, alive, 1020 days 647.7
DO50804 81 years, male, NA, stage:2, alive, 720 days 631.4
DO45153 77 years, female, NA, stage:2, alive, 1380 days 624.7
DO23551 73 years, male, NA, stage:3, dead, 150 days 621.0
DO45193 68 years, female, NA, stage:4, dead, 120 days 617.6
DO50817 75 years, male, NA, stage:2, alive, 390 days 617.4
DO227643 79 years, male, NA, stage:2, alive, 1260 days 617.0
DO48743 69 years, female, NA, stage:2, alive, 570 days 608.1
DO45107 63 years, female, NA, stage:2, alive, 1710 days 606.0
DO45161 74 years, male, NA, stage:2, dead, 540 days 605.6
DO48715 58 years, female, NA, stage:2, dead, 690 days 594.1
DO23534 60 years, male, NA, stage:2, alive, 840 days 590.9
DO23547 74 years, male, NA, stage:1, alive, 1020 days 590.5
DO23530 53 years, male, NA, stage:4, dead, 180 days 584.5
DO23546 63 years, male, NA, stage:2, alive, 1050 days 577.6
DO50806 70 years, male, NA, stage:4, alive, 540 days 577.6
DO23515 71 years, male, NA, stage:2, alive, 1230 days 570.6
DO23509 60 years, male, NA, stage:3, dead, 780 days 570.6
DO50809 56 years, male, NA, stage:3, dead, 720 days 569.6
DO50778 60 years, male, NA, stage:4, alive, 630 days 565.4
DO45217 69 years, female, NA, stage:3, dead, 270 days 546.3
DO45115 81 years, male, NA, stage:2, alive, 840 days 544.7
DO48706 72 years, male, NA, stage:2, alive, 870 days 533.8
DO50845 72 years, male, NA, stage:3, alive, 210 days 529.0
DO45241 49 years, male, NA, stage:1, alive, 1080 days 528.0
DO45135 77 years, male, NA, stage:1, alive, 1410 days 528.0
DO50799 66 years, female, NA, stage:2, alive, 540 days 527.0
DO45237 58 years, male, NA, stage:2, alive, 900 days 514.2
DO45157 62 years, male, NA, stage:2, alive, 1980 days 512.1
DO45133 64 years, male, NA, stage:3, dead, 660 days 500.1
DO48728 74 years, female, NA, stage:2, alive, 150 days 494.7
DO50840 49 years, male, NA, stage:2, alive, 330 days 493.9
DO48720 62 years, female, NA, stage:2, alive, 570 days 493.5
DO45235 68 years, female, NA, stage:1, alive, 900 days 491.7
DO45163 76 years, male, NA, stage:2, alive, 960 days 485.7
DO45093 71 years, male, NA, stage:2, dead, 720 days 476.9
DO48732 73 years, male, NA, stage:3, alive, 630 days 466.7
DO45275 65 years, male, NA, stage:3, dead, 10 days 457.7
DO45181 84 years, female, NA, stage:2, alive, 1200 days 456.1
DO48727 81 years, female, NA, stage:2, dead, 390 days 440.5
DO23531 78 years, female, NA, stage:3, alive, 900 days 435.3
DO50808 68 years, male, NA, stage:2, alive, 570 days 432.5
DO48693 71 years, male, NA, stage:2, alive, 900 days 431.3
DO48723 73 years, male, NA, stage:1, alive, 600 days 427.6
DO45253 50 years, male, NA, stage:2, alive, 870 days 420.0
DO48716 71 years, male, NA, stage:2, alive, 720 days 419.5
DO50822 66 years, male, NA, stage:2, alive, 510 days 419.2
DO45209 70 years, male, NA, stage:4, alive, 1350 days 418.5
DO23518 67 years, male, NA, stage:2, alive, 1320 days 414.7
DO50850 74 years, male, NA, stage:3, alive, 720 days 411.1
DO48725 66 years, male, NA, stage:1, alive, 780 days 407.6
DO45263 67 years, male, NA, stage:3, dead, 270 days 405.3
DO23542 66 years, male, NA, stage:3, alive, 960 days 395.2
DO48730 73 years, female, NA, stage:2, alive, 630 days 390.8
DO45225 69 years, male, NA, stage:1, alive, 1050 days 390.2
DO23543 63 years, male, NA, stage:2, alive, 1020 days 388.0
DO50793 76 years, male, NA, stage:4, alive, 540 days 386.6
DO23511 83 years, female, NA, stage:3, dead, 180 days 378.7
DO45123 78 years, female, NA, stage:2, dead, 570 days 366.6
DO50815 62 years, male, NA, stage:3, alive, 150 days 355.6
DO23526 66 years, male, NA, stage:3, alive, 1050 days 354.7
DO45125 58 years, male, NA, stage:3, alive, 1680 days 354.4
DO50774 68 years, female, NA, stage:2, alive, 720 days 348.9
DO45175 74 years, male, NA, stage:2, alive, 1140 days 344.0
DO50791 79 years, female, NA, stage:1, dead, 480 days 337.4
DO23540 73 years, male, NA, stage:1, alive, 750 days 335.4
DO23545 67 years, male, NA, stage:2, dead, 570 days 334.5
DO48719 80 years, male, NA, stage:2, alive, 690 days 331.7
DO23525 71 years, male, NA, stage:4, alive, 1050 days 330.0
DO23532 71 years, female, NA, stage:1, alive, 960 days 329.8
DO45201 49 years, male, NA, stage:1, alive, 900 days 327.4
DO45127 73 years, male, NA, stage:3, dead, 420 days 326.8
DO45185 89 years, male, NA, stage:2, alive, 600 days 325.9
DO45165 75 years, male, NA, stage:2, alive, 690 days 319.2
DO23549 74 years, male, NA, stage:3, alive, 990 days 300.0
DO45273 62 years, male, NA, stage:2, alive, 480 days 299.6
DO48704 68 years, female, NA, stage:3, alive, 750 days 294.2
DO45265 73 years, male, NA, stage:3, alive, 1020 days 277.7
DO45267 73 years, male, NA, stage:3, dead, 570 days 264.9
DO50829 78 years, male, NA, stage:3, alive, 570 days 263.9
DO48672 81 years, male, NA, stage:2, alive, 450 days 250.6
DO45251 57 years, female, NA, stage:2, alive, 900 days 245.8
DO50814 83 years, male, NA, stage:3, alive, 420 days 243.1
DO45169 74 years, male, NA, stage:3, alive, 1350 days 242.7
DO50798 77 years, male, NA, stage:3, dead, 30 days 241.7
DO48747 62 years, male, NA, stage:3, alive, 540 days 223.4
DO50785 37 years, male, NA, stage:4, dead, 90 days 220.6
DO45117 73 years, female, NA, stage:2, dead, 1110 days 217.5
DO50803 62 years, female, NA, stage:1, alive, 540 days 211.8
DO45249 57 years, male, NA, stage:1, alive, 630 days 205.5
DO45287 74 years, male, NA, stage:1, alive, 390 days 197.3
DO45239 42 years, male, NA, stage:2, alive, 870 days 182.6
DO48682 72 years, female, NA, stage:3, dead, 120 days 180.5
DO45221 75 years, female, NA, stage:4, dead, 390 days 178.7
DO45283 60 years, male, NA, stage:3, alive, 510 days 177.9
DO45307 54 years, female, NA, stage:4, dead, 240 days 130.8
DO23523 52 years, male, NA, stage:3, alive, 1080 days 129.6
DO45279 67 years, male, NA, stage:3, alive, 1290 days 102.3
DO45277 64 years, male, NA, stage:3, alive, 600 days 83.3
DO45211 76 years, male, NA, stage:3, alive, 240 days 79.1
DO45301 56 years, male, NA, stage:2, dead, 1440 days 58.9
DO45305 66 years, male, NA, stage:4, alive, 300 days 45.6
DO45289 78 years, female, NA, stage:3, alive, 360 days 37.2
DO45285 59 years, male, NA, stage:3, alive, 480 days 25.6
DO45297 61 years, female, NA, stage:4, dead, 1260 days 24.7
DO45145 78 years, male, NA, stage:3, dead, 60 days 20.6
DO50844 75 years, male, NA, stage:4, alive, 300 days 18.7
DO48751 68 years, male, NA, stage:2, dead, 480 days 17.4
DO45303 62 years, female, NA, stage:3, alive, 990 days 17.3
DO23519 65 years, male, NA, stage:3, alive, 630 days 10.7
DO45245 75 years, female, NA, stage:2, dead, 240 days 7.8
DO45299 70 years, female, NA, stage:1, alive, 1440 days 6.7
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
227 Tumor 2.2
877 Tumor 2.1
363 Tumor 2.0
881 Tumor 1.6
863 Tumor 1.6
817 Tumor 1.5
343 Tumor 1.4
455 Tumor 1.4
975 Tumor 1.4
283 Tumor 1.3
311 Tumor 1.3
671 Tumor 1.2
375 Tumor 1.2
545 Tumor 1.2
355 Tumor 1.2
297 Tumor 1.2
713 Tumor 1.1
471 Tumor 1.0
813 Tumor 1.0
421 Tumor 1.0
697 Tumor 1.0
641 Tumor 1.0
921 Tumor 0.9
715 Tumor 0.9
131 Tumor 0.9
425 Tumor 0.9
517 Tumor 0.8
557 Tumor 0.8
447 Tumor 0.8
385 Tumor 0.7
883 Tumor 0.7
743 Tumor 0.7
187 Tumor 0.7
141 Tumor 0.7
223 Tumor 0.7
563 Tumor 0.7
444 Normal 0.7
917 Tumor 0.6
191 Tumor 0.6
145 Tumor 0.6
823 Tumor 0.6
461 Tumor 0.6
525 Tumor 0.6
463 Tumor 0.6
383 Tumor 0.6
665 Tumor 0.6
192 Normal 0.5
137 Tumor 0.5
1045 Tumor 0.5
535 Tumor 0.5
277 Tumor 0.5
427 Tumor 0.5
185 Tumor 0.5
857 Tumor 0.4
515 Tumor 0.4
365 Tumor 0.4
135 Tumor 0.4
785 Tumor 0.3
527 Tumor 0.3
983 Tumor 0.3
943 Tumor 0.3
923 Tumor 0.3
635 Tumor 0.3
1041 Tumor 0.3
536 Normal 0.2
963 Tumor 0.2
313 Tumor 0.2
483 Tumor 0.2
958 Normal 0.2
384 Normal 0.2
224 Normal 0.2
967 Tumor 0.2
433 Tumor 0.2
261 Tumor 0.2
491 Tumor 0.2
113 Tumor 0.1
814 Normal 0.1
221 Tumor 0.1
331 Tumor 0.1
647 Tumor 0.1
777 Tumor 0.1
884 Normal 0.1
492 Normal 0.1
213 Tumor 0.1
393 Tumor 0.1
285 Tumor 0.1
953 Tumor 0.0
573 Tumor 0.0
391 Tumor 0.0
422 Normal 0.0
1027 Tumor 0.0
124 Normal 0.0
878 Normal 0.0
443 Tumor 0.0
328 Normal 0.0
387 Tumor 0.0
327 Tumor 0.0
314 Normal 0.0
741 Tumor 0.0
361 Tumor 0.0
394 Normal 0.0
386 Normal 0.0
142 Normal 0.0
395 Tumor 0.0
388 Normal 0.0
217 Tumor 0.0
228 Normal 0.0
516 Normal -0.1
523 Tumor -0.1
981 Tumor -0.1
524 Normal -0.1
615 Tumor -0.1
553 Tumor -0.1
364 Normal -0.1
354 Normal -0.1
1028 Normal -0.1
448 Normal -0.1
146 Normal -0.1
627 Tumor -0.1
195 Tumor -0.1
428 Normal -0.1
474 Normal -0.1
964 Normal -0.1
868 Normal -0.1
818 Normal -0.1
514 Normal -0.1
472 Normal -0.1
415 Tumor -0.1
367 Tumor -0.1
1046 Normal -0.1
123 Tumor -0.1
1042 Normal -0.1
874 Normal -0.2
312 Normal -0.2
451 Tumor -0.2
298 Normal -0.2
392 Normal -0.2
464 Normal -0.2
368 Normal -0.2
462 Normal -0.2
188 Normal -0.2
218 Normal -0.2
416 Normal -0.2
1022 Normal -0.2
473 Tumor -0.2
284 Normal -0.2
852 Normal -0.2
353 Tumor -0.2
926 Normal -0.2
467 Tumor -0.2
786 Normal -0.2
498 Normal -0.2
431 Tumor -0.2
366 Normal -0.2
938 Normal -0.2
672 Normal -0.2
136 Normal -0.2
916 Normal -0.2
214 Normal -0.2
211 Tumor -0.2
882 Normal -0.2
617 Tumor -0.2
1015 Tumor -0.2
913 Tumor -0.2
815 Tumor -0.2
982 Normal -0.2
867 Tumor -0.2
538 Normal -0.2
915 Tumor -0.2
125 Tumor -0.2
866 Normal -0.2
456 Normal -0.2
268 Normal -0.2
755 Tumor -0.2
432 Normal -0.2
1032 Normal -0.2
126 Normal -0.3
526 Normal -0.3
161 Tumor -0.3
918 Normal -0.3
484 Normal -0.3
482 Normal -0.3
666 Normal -0.3
286 Normal -0.3
618 Normal -0.3
412 Normal -0.3
662 Normal -0.3
912 Normal -0.3
436 Normal -0.3
257 Tumor -0.3
396 Normal -0.3
468 Normal -0.3
278 Normal -0.3
648 Normal -0.3
977 Tumor -0.3
147 Tumor -0.3
196 Normal -0.3
356 Normal -0.3
664 Normal -0.3
362 Normal -0.3
571 Tumor -0.3
642 Normal -0.3
937 Tumor -0.3
424 Normal -0.3
778 Normal -0.3
132 Normal -0.3
271 Tumor -0.3
737 Tumor -0.3
954 Normal -0.3
534 Normal -0.3
546 Normal -0.3
756 Normal -0.3
558 Normal -0.3
685 Tumor -0.3
1043 Tumor -0.3
376 Normal -0.3
1044 Normal -0.3
172 Normal -0.3
466 Normal -0.3
446 Normal -0.3
138 Normal -0.3
423 Tumor -0.3
957 Tumor -0.4
452 Normal -0.4
862 Normal -0.4
816 Normal -0.4
518 Normal -0.4
858 Normal -0.4
968 Normal -0.4
222 Normal -0.4
513 Tumor -0.4
478 Normal -0.4
745 Tumor -0.4
864 Normal -0.4
636 Normal -0.4
465 Tumor -0.4
481 Tumor -0.4
746 Normal -0.4
494 Normal -0.4
716 Normal -0.4
873 Tumor -0.4
212 Normal -0.4
976 Normal -0.4
1025 Tumor -0.4
445 Tumor -0.4
564 Normal -0.4
493 Tumor -0.4
344 Normal -0.4
914 Normal -0.4
358 Normal -0.4
574 Normal -0.4
426 Normal -0.4
258 Normal -0.4
744 Normal -0.4
984 Normal -0.4
477 Tumor -0.4
262 Normal -0.4
572 Normal -0.4
956 Normal -0.4
723 Tumor -0.4
414 Normal -0.4
114 Normal -0.4
742 Normal -0.4
616 Normal -0.4
1014 Normal -0.4
824 Normal -0.4
341 Tumor -0.4
722 Normal -0.5
352 Normal -0.5
1016 Normal -0.5
728 Normal -0.5
924 Normal -0.5
232 Normal -0.5
695 Tumor -0.5
111 Normal -0.5
721 Tumor -0.5
922 Normal -0.5
628 Normal -0.5
272 Normal -0.5
1026 Normal -0.5
851 Tumor -0.5
413 Tumor -0.5
528 Normal -0.5
488 Normal -0.5
435 Tumor -0.5
554 Normal -0.5
171 Tumor -0.5
925 Tumor -0.5
944 Normal -0.5
696 Normal -0.5
231 Tumor -0.5
911 Tumor -0.5
148 Normal -0.5
865 Tumor -0.6
861 Tumor -0.6
1031 Tumor -0.6
727 Tumor -0.6
332 Normal -0.6
738 Normal -0.6
162 Normal -0.6
434 Normal -0.6
112 Tumor -0.6
978 Normal -0.6
186 Normal -0.6
568 Normal -0.6
686 Normal -0.6
714 Normal -0.6
661 Tumor -0.6
351 Tumor -0.6
663 Tumor -0.6
1021 Tumor -0.6
411 Tumor -0.7
952 Normal -0.7
487 Tumor -0.7
342 Normal -0.7
128 Normal -0.7
127 Tumor -0.7
698 Normal -0.7
497 Tumor -0.7
533 Tumor -0.8
357 Tumor -0.8
567 Tumor -0.8
966 Normal -0.8
724 Normal -0.8
951 Tumor -0.9
955 Tumor -0.9
267 Tumor -0.9
1013 Tumor -0.9
537 Tumor -0.9
965 Tumor -1.1
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA005825
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Cholangiocarcinoma
Carcinoma, Hepatocellular, NOS

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org